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Future perspectives in psychotherapy
Abstract
To date, the effectiveness of psychotherapy for the treatment of most mental disorders is empirically
well documented. From an "evidence-based medicine" viewpoint, psychotherapy, as compared to other
treatments in medicine, can be regarded as one of the most effective therapeutic approaches. The
superiority of psychotherapy over pharmacotherapy is particularly pronounced in long-term treatment
outcome studies. It is especially cognitive behavioral approaches, such as exposure response
management and cognitive restructuring that have shown strong evidence of their efficacy and
effectiveness in various populations and settings. However, evidence-based medicine is by definition
oriented toward the past, as it only informs us about the well-established, empirically supported
treatments. If we rely only on the currently available scientific evidence, new developments will be
blocked. Since, for instance, many patients decline treatment, or do not seek professional help at all,
there is a need for improvements regarding acceptance of established therapies. In addition, there ought
to be scope for new, creative approaches, for which scientific evidence is not yet available. Promising
developments include the mindfulness-based therapies, well-being therapy, the use of cognitive
enhancers such as D-cycloserine, and Web-based therapies. There is also a trend in psychotherapy
training toward teaching specific, disorder-oriented protocols or modules rather than universally
applicable therapies. Finally, given the globalization of our societies, culture-sensitive psychotherapists
should try to understand the cultural components of a patient's illness and help-seeking behaviors, as
well as their expectations with regard to treatment.
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Abstract 
To date, the effectiveness of psychotherapy for the treatment of most mental disorders is empirically 
well documented. From an “evidence-based medicine” viewpoint, psychotherapy, as compared to 
other treatments in medicine, can be regarded as one of the most effective therapeutic approaches. 
The superiority of psychotherapy over pharmacotherapy is particularly pronounced in long-term 
treatment outcome studies. It is especially cognitive behavioral (CBT) approaches, such as exposure 
response management and cognitive restructuring, that have shown strong evidence of their efficacy 
and effectiveness in various populations and settings. However, evidence-based medicine is by 
definition oriented towards the past, as it only informs us about the well-established, empirically 
supported treatments. If we rely only on the currently available scientific evidence, new developments 
will be blocked. Since, for instance, many patients decline treatment, or do not seek professional help 
at all, there is a need for improvements regarding acceptance of established therapies. In addition, 
there ought to be scope for new, creative approaches, for which scientific evidence is not yet available. 
Promising developments include the mindfulness-based therapies, well-being therapy, the use of 
cognitive enhancers such as D-cycloserine, and web-based therapies. There is also a trend in 
psychotherapy training towards teaching specific, disorder-oriented protocols or modules rather than 
universally applicable therapies. Finally, given the globalization of our societies, culture-sensitive 
psychotherapists should try to understand the cultural components of a patient’s illness and help-
seeking behaviors, as well as their expectations with regard to treatment. 
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 1 Psychotherapy: status quo 
1.1 What is psychotherapy? 
According to Senf and Broda’s textbook [30], psychotherapy is a scientifically-based form of 
professional action within the framework of the public health-care system and in accordance with its 
rules. Psychotherapy positioned in this way is based on scientifically comprehensible and empirically 
supported theories of illness, healing and treatment. Moreover, psychotherapy uses theoretically 
derived and empirically supported procedures, methods and settings to bring about a targeted change 
in experience and behavior to treat or prevent illnesses, disorders or complaints, whose causes are 
wholly or partly psychological. Such a procedure presupposes a thorough diagnosis and a differential 
diagnosis as well as a qualified differential indication. Moreover, psychotherapy is practised with 
treatment targets formulated beforehand and evaluated afterwards. At the end of their definition, Senf 
and Broda stress that psychotherapy is conducted by professional psychotherapists, whose 
professional qualification has been demonstrated through examination, maintains ethical principles 
and standards and, finally, satisfies measures of quality assurance and adheres to the economic 
imperative [30]. 
 
In short, a scientifically based psychotherapy is rooted in empirically supported theories of illness, 
healing and treatment. It applies theoretically derived and evidence-based procedures to try and bring 
about a deliberate change in the experience and behavior of patients and, in so doing, treats or 
prevents mental illnesses. 
 
1.2 Does it work? 
Psychotherapy can be considered as one of medicine’s most effective therapeutic approaches. By no 
means does psychotherapy need to hide away, for instance, from the comparison with drug treatment 
or surgery. Take, for example, the prescribing of acetylsalicylic acid to prevent myocardial infarction, 
which has an effect size (treated versus untreated) of .07. Medication for rheumatoid arthritis scores 
.61, which is already in the mid-range of effect sizes, whereas aorto-coronary bypass surgery has a 
comparatively high effect size of .80. The effect size of psychotherapy is .88, which is within the same 
order of magnitude – and that is taking all psychotherapeutic approaches together. If the cognitive 
behavioral therapies are considered separately, their effect size is as high as 1.21 [8, 10, 16, 17]. 
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 Across the majority of mental disorders, most of the therapeutic effect of psychotherapy is achieved 
within the first ten to twenty sessions. This concerns not only the reduction in symptoms, but also the 
improvement in the patients’ subjective feeling of wellbeing and their psycho-social functional level [16, 
18]. On the other hand, there are of course patients with chronic mental disorders, such as severe 
personality disorders, who do need long-term psychotherapy, sometimes over many years [15]. There 
is also good evidence for the long-term stability of the results once the psychotherapy has been 
completed. However, this applies, in particular, for cognitive behavioral therapy, but much less so for 
psychodynamic treatments and relaxation techniques [20]. 
 
1.3 Use of effective treatments in clinical practice 
Despite all these positive reports on the effectiveness of psychotherapy, one big problem still persists: 
those therapeutic approaches whose effectiveness has been scientifically proven are still used much 
too little in everyday clinical psychotherapeutic practice. This was demonstrated, for example, in a 
large representative study carried out in Switzerland into the treatment of anxiety and depression to 
establish which therapeutic approaches were actually used in real routine practice. Patients with 
anxiety and depressive disorders were only relatively rarely given treatments whose efficacy was well 
documented (cognitive therapy and behavioral therapy: 12%, hypnosis and relaxation techniques: 
39% of all cases), whereas supportive counseling and pharmacotherapy, which have been 
demonstrated to promise less lasting success, were used in 70-90% of cases (Margraf, in 
preparation). It has been known for a long time that only a small percentage of patients suffering from 
anxiety or depressive disorders are treated by adequately trained specialists. The study just 
mentioned shows, moreover, that, of these few patients who have access to professional treatment, 
only a small proportion, in turn, benefit from evidence-based therapies. 
 
Thus, in Europe, we find ourselves faced with a somewhat strange situation. There are many good, 
fully trained and clinically experienced psychotherapists working in specialized institutions or in private 
practice. Today, very effective treatment options are available for the most frequently occurring mental 
disorders, and most people have a health insurance which would cover a large part of the treatment 
costs. Yet most sufferers of mental disorders are either not receiving any professional treatment at all, 
or the effectiveness of one they are receiving is not scientifically proven. 
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2 Evidence-based psychotherapy 
Chambless and Hollon postulate that the following criteria would have to be met for a therapeutic 
approach to be “evidence-based” and/or “empirically supported”: the efficacy of the approach must 
have been demonstrated by a series of randomized controlled trials (RCTs), using appropriate 
samples and control groups; the samples must have been adequately described; valid and reliable 
outcome assessments must have been used; and, finally, the results must have been replicated by at 
least one independent group of researchers [2]. Foa and colleagues make the point that the use of 
more rigorous scientifc methods in psychotherapy outcome research has increased dramatically in the 
course of the past 25 years. As a representative example, they describe for the field of traumatic 
stress research the following features which a well-controlled trial should have [6]: 
 Clearly defined target symptoms 
 Reliable and valid measures that allow to establish reliably both symptom severity as well as 
diagnostic status 
 Use of blinded evaluators  
 Assessor training to ensure inter-rater reliability and to prevent evaluator drift 
 Manualized, replicable, specific treatment protocols 
 Equipoise with regard to treatment conditions 
 Unbiased assignment to treatment 
 Treatment adherence ratings 
 Data analysis conducted according to accepted procedures 
 
2.1 Efficacy versus effectiveness 
The purpose of efficacy studies is to examine whether or not an intervention has an effect in ideal 
conditions in which all the influences can be measured and monitored with precision. It may happen in 
such trials that the patients are not representative of the everyday clinical situation or only partially so. 
The research design for efficacy studies stresses internal validity, and for this purpose it is common to 
perform completers analyses. If such a trial is carried out in properly controlled conditions it may, 
however, supply valuable information as regards the specificity of the intervention. 
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Effectiveness studies are different in that they ask the question as to whether or not a particular 
intervention produces an effect in real clinical conditions. It thus follows that the patients selected for 
the trial should be more representative of the everyday clinical population. This sort of study design 
stresses external validity. It is typical for effectiveness studies to perform intent-to-treat analyses. Such 
trials, however, provide only limited information on the specificity of an intervention.  
 
Thus both efficacy and effectiveness studies have their specific advantages and disadvantages. It 
would therefore be wrong to want to play them off against one another. On the contrary, it is possible 
for them to complement one another in a meaningful way, quite apart from the fact that case studies, 
naturalistic studies, process research and other approaches can provide important additional 
information to the overall judgment of a therapeutic approach. In subsequent stages of research, 
attempts are made to understand the mechanism of action more precisely by performing dismantling 
or component control studies. 
 
2.2 Dissemination of evidence-based therapies 
Why is it that, although effective psychotherapeutic interventions are available today for the 
commonest mental disorders, the majority of patients either receive no professional treatment at all or, 
if they do make their way into professional hands, the therapy that is provided will often not be one for 
which there is sufficient empirical support? 
 
One reason is that today most psychotherapists are still not adequately trained in empirically 
supported treatments. Secondly, many psychotherapists do not like working with treatment manuals; 
in most cases, they have had no experience with using treatment manuals and are afraid that following 
treatment steps laid down in a manual will constrain them from giving free reign to their creativity. The 
other side to this is that both patients and health insurance companies are increasingly demanding the 
use of evidence-based procedures. Therefore, evidence-based medicine is going to shape our 
everyday lives as therapists. However, having said that, it should also be kept in mind that evidence-
based medicine is, by its very definition, based on, and oriented towards, the past; it informs us of the 
results that have been produced by research up until the present day. If a new intervention has not 
been empirically studied, it does not mean that it is not effective – it merely indicates that, for the time 
being, there is still no scientific evidence of its effectiveness.  
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 A greater dissemination of evidence-based therapies in clinical practice is absolutely indispensable. 
However, if we simply rely on the principles of evidence-based medicine and leave it at that, things will 
come to a standstill and creative further developments and new developments will be rendered 
impossible. Genuine scientific progress is only possible if there are creative therapists and researchers 
who are repeatedly willing to risk trying out new ideas. However, these innovations must, in their turn, 
face up to critical scientific scrutiny. If sober examination proves that they are ineffective, we must 
abandon them again, no matter how attractive and promising they might appear to be. If they are 
effective, these new developments will sooner or later make their way onto the palette of treatments 
from which the therapist can choose – perhaps as a totally new approach in their own right, perhaps 
as a new technique, or perhaps as a complement to existing interventions. 
 
Roth and Fonagy, too, place innovative practice at the beginning of a feedback loop – actually one 
with several sub-loops, within which the field of psychotherapy develops further, finally resulting in 
improved psycho-social care [25]. They see innovative practice as stimulating the evaluation of case 
series. New concepts emerging from this are taken up by psychotherapy research and are 
investigated in randomized controlled trials. The results of this research are fed into professional 
consensus conferences and have their impact on the development of guidelines. When the latter are, 
in turn, put into effect, they change clinical practice and lead to an improvement in clinical care through 
quality-control measures. In addition to this, they also bring about adaptations in training at all levels 
(initial, advanced and continuous). The experience from clinical practice combined with data from 
quality management might then provide the occasion for a new round of innovative adaptations in the 
way patients are dealt with clinically, and, in that way, the creative circle will have completed its 360° 
turn. Additionally, the process is also sustained and driven forward by external stimuli and inputs, 
originating, for instance, in basic neurobiological research or innovations in psychopathology. 
 
 
3 Promising developments in psychotherapy 
If existing psychotherapies are as effective and successful as stated above, why should there be any 
need at all for further progress? Is it not possible to consider psychotherapy as a form of treatment that 
has reached maturity? Would it thus not be our priority to make sure that the effective interventions 
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were disseminated as widely as feasible, so that as many patients as possible would be able to benefit 
from them? Yes, but there are still several good reasons [28] militating in favor of further 
enhancements in the spectrum of psychotherapeutic interventions as well as advancing the further 
continuation of developments, additions and extensions to this spectrum. Here are some of those 
reasons: 
 Not all patients are willing to subject themselves to an empirically supported therapy. Exposure, 
for example, is considered today to be the treatment of choice for most anxiety disorders, 
including obsessive compulsive disorders. There are, however, patients who, for comprehensible 
reasons, cannot agree, at least at a given point in time, to undergo confrontation therapy of this 
nature. 
 The overall dropout rates for empirically supported therapies are approximately 20% [1].  
 Around 50% of the patients who complete an evidence-based treatment schedule with success 
and with a clinically relevant symptom reduction, will still satisfy the diagnostic criteria for the 
disorder that took them into the treatment to begin with [23, 31]. 
 Around 50% of patients do not attain a satisfactory psycho-social functional level, even if their 
symptoms have decreased significantly [21, 23]. At the end of treatment, many patients are still 
impaired as regards their ability to perform employed work, the quality of their relationships, and 
their general satisfaction with life. 
 One final point is that there is still too little on offer today for patients who do not find their way into 
psychotherapy, for reasons such as not finding a therapist speaking their language, not being able 
to attend a psychotherapeutic practice on account of a physical disability, or fearing stigmatization 
on account of their exposed position within society. 
 
Against the background of all the reasons just outlined, the following sections go on to present a 
number of examples of creative further developments or new developments. These are worthy of 
discussion, since they have the potential of contributing to more finely tuned differentiation amongst 
the possible psychotherapeutic interventions currently available. 
 
3.1 Mindfulness and acceptance 
The “mindfulness-based therapies” are certainly to be counted amongst the most important further 
developments and additions to cognitive behavioral therapies in recent years [9]. Kabat-Zinn detached 
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mindfulness from its original Buddhist context and developed a form of training in mindfulness 
meditation as a complement for treatment of chronic pain, known as “mindfulness-based stress 
reduction” [11]. It was about ten years ago that cognitive-behavioral therapy took up the notion of 
mindfulness and integrated it as an addition in its therapeutic concepts, which up until then had been 
comprised almost exclusively of strategies focused on bringing about changes. After the “cognitive 
shift” of the 1980s and the “emotional shift” of the 1990s, the integration of elements based on 
mindfulness in the first decade of the 21st century is referred to as the “third wave” (or “shift”) in 
cognitive-behavioral therapy. In the meantime, mindfulness-based cognitive therapy (MBCT) has 
yielded good evidence of its effectiveness for major depression, treatment-resistant depression and 
residual depressive symptoms [19, 32]. Other mental disorders are currently undergoing evaluation. 
 
3.2 Well-being therapy 
On the basis of Ryff’s multidimensional cognitive model of psychological wellbeing [26, 27], Fava 
developed a short, manual-based psychotherapy. Conceptually, this differs enormously from 
traditional psychotherapeutic approaches. In a course of eight clearly structured psycho-educative, 
directive therapy sessions focused on solutions, the therapist does not talk to the patient about 
problems or symptoms. On the contrary, the focus is solely on enhancing the patient’s sense of 
wellbeing [3]. The aim of the treatment is to achieve an improvement in the following six dimensions: 
environmental mastery, personal growth, purpose in life, autonomy, self-acceptance, and positive 
relations with others. The techniques used are self-observation, keeping a structured diary, cognitive 
restructuring, problem-solving strategies, self-assertiveness training, planned activities for mastering 
daily life, leisure and homework. Well-being therapy has been used successfully for preventing relapse 
in recurrent depression [4, 5]. However, it also appears to perform well for treatment-resistant 
depressions and anxiety disorders as well as for psycho-somatic disorders and post-traumatic stress 
disorders. 
 
3.3 Cognitive enhancers 
D-cycloserine was developed in the 1950s for the treatment of tuberculosis. It was only recently 
discovered that the compound can also influence learning behavior. It was demonstrated that the 
administration of 50 mg of D-cycloserine immediately prior to each session improved the effect of 
exposure therapy for fear of heights [24]. This effect appears to be related to the substance properties 
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as a partial glutamate receptor agonist. It has also been administered successfully to augment CBT 
interventions for other anxiety disorders and a series of other mental disorders, including depression, 
eating disorders, substance dependence, and schizophrenia [22]. 
 
The experience with D-cycloserine shows that there are no longer any valid grounds for maintaining 
the earlier distinction and clear demarcation between “psychological” and “pharmacological” 
approaches to therapy. These two principles of action have now been thoroughly intermixed and act 
as valuable complements for one another. There can be no doubt that this development is going to go 
further. There are, for instance, already examples of hormones, such as cortisol or oxytocin, being 
used in combination with psychotherapy. 
 
3.4 Web-based therapies 
Starting around the mid 1990s, internet-based treatment protocols have been developed in which 
patients and therapists never come face-to-face. Many internet-based self-help offers are available 
today, and there are also psychotherapies in the strict sense of the term. They seem to function well 
for various types of mental disorders, and are intensively used, although it appears that, for the time 
being, their users are primarily younger patients. As an example, “Interapy” is a fully web-based writing 
therapy for post-traumatic stress disorder [14]. The treatment is comprised of ten writing sessions, 
divided into three phases: self-confrontation, cognitive restructuring and social sharing. Initial 
investigations into Interapy show substantial and sustained symptom reduction over a follow-up period 
of 18 months. The vast majority of the patients treated indicated that they had experienced the internet 
contact with their therapists as “personal”, that they had found the internet to be an agreeable medium 
of communication and, interestingly, that it had not been a problem for them never to have come face-
to-face with their therapists [13, 34]. 
 
3.5 Integrated training in evidence-based, disorder-specific therapies 
There has been a recent trend to move more and more away from universally applicable therapies 
towards the development of disorder-specific protocols or therapeutic modules for specific problems 
such as emotion regulation, which can occur in conjunction with a whole range of disorders. 
Accordingly, in the field of advanced and continuous training, there is an ever-increasing number of 
programs on offer aiming to impart therapeutic knowledge and skills concerning empirically supported 
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therapeutic approaches within a defined diagnostic spectrum. For instance, psychotherapists with 
clinical experience, who would like to intensify their knowledge and skills in the area of 
psychotraumatology, can now enroll in a master’s course in psychotraumatology at Zurich University 
(www.mas-psychotraumatology.uzh.ch). Its main emphasis is on mediating evidence-based 
treatments for post-traumatic stress disorder. The course is built on “blended learning”, which means 
that traditional learning methods (lectures, problem-oriented learning in small groups and group 
supervision) are combined with e-learning (online learning resources, web forum, podcasts and so on). 
This is a setup that facilitates asynchronous learning, so that it is possible for students from the whole 
German-speaking world to enroll [29]. 
 
3.6 Culture-sensitive psychotherapy 
Tseng defines culture as a dynamic concept referring to a set of beliefs, attitudes, and value systems, 
that derive from early stages of life through enculturation, and become an internal mode of regulating 
behavior, action, and emotion [33]. Thus, culture is not static, but changing continuously across 
generations, responding to ever-changing environmental demands. Furthermore, culture in this sense 
is specific for each individual and therefore much more important than ethnicity or race. Experienced 
therapists usually tailor psychotherapy to each patient’s particular situation, to the nature of 
psychopathology, to the stage of therapy, and so on. Treatment could be a lot more effective, 
however, when the cultural dimension is factored in. The resulting culturally relevant, culture-sensitive, 
or culture-competent psychotherapy involves trying to understand how culture enhances the meaning 
of the patient’s life history, the cultural components of a patient’s illness and help-seeking behaviors, 
as well as the patient’s expectations with regard to treatment. 
 
 
4 The profile of future psychotherapists 
More than a decade ago, Nobel prize winner Eric Kandel wrote that “Insofar as psychotherapy or 
counseling is effective and produces long-term changes in behavior, it presumably does so through 
learning, by producing changes in gene expression that alter the strength of synaptic connections and 
structural changes that alter the anatomical pattern of interconnections between nerve cells of the 
brain. As the resolution of brain imaging increases, it should eventually permit quantitative evaluation 
of the outcome of psychotherapy” [12]. Today, “neuropsychotherapy” [cf. reference 7 and the 
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contribution by Walter and Berger in this issue] has become a reality. Therefore, modern 
psychotherapists are required to integrate profound knowledge and advanced skills not only in 
developmental psychology, psychological theories, psychopathology, and intervention techniques, but 
in neurosciences and anthropology as well. We need to encourage translational research that 
transfers advances in basic science to clinical applications, foster the clinician-researcher dialogue, 
and promote more interdisciplinary collaborative learning. 
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